A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Th...

af Goldman, Jonathan W., Mazieres, Julien, Barlesi, Fabrice, Dragnev, Konstantin H., Koczywas, Marianna, Göskel, Tuncay, Cortot, Alexis B., Girard, Nicolas, Wesseler, Claas, Bischoff, Helge, Nadal, Ernest, Park, Keunchil, Lu, Shun, Taus, Alvaro, Cobo, Manuel, Estrem, Shawn T., Wijayawardana, Sameera R., Turner, Kellie, Oakley, Gerard Joseph, Hurt, Karla C., Chiang, Alan Y., Hossain, Anwar M., John, William J., Paz-Ares, Luis
Udgivet i Front Oncol (2020)